Lymphoma, a type of blood cancer, occurs when white blood cells begin behaving abnormally, and do not properly protect the body from infections and diseases. There are two main types of lymphoma, Hodgkin Lymphoma and Non-Hodgkin Lymphoma, and although between 30 and 60 percent of patients with lymphoma can be cured through different treatment methods like chemotherapy and radiation therapy, there are still problems with lymphoma being resistant to some drugs used. The National Cancer Institute, part of the NIH, recently awarded the University of Arizona Tucson a 5-year, $1.59 million life science grant to study methods of combating drug resistance in lymphoma treatments.Read More
What would you do if you were unable to find a veterinarian for your beloved dog or cat if they became sick? People who serve as caretakers for animals love their pets. The state of Arizona, however, has a shortage of trained veterinarians due to the fact that there is minimal animal medicine programs in the state. One university seeks to address this problem with a new program in veterinary medicine at the University of Arizona.
Lab suppliers working to find markets where life science professionals keep their well funded research labs and advanced research facilities stocked with life science products may want to take a closer look at the University of Arizona, Tucson. This nationally renowned research university is home to over 57 shared research facilities and a wealth of research funding. The University of Arizona, Tucson website states, “This extensive offering provides faculty, scientists and students with access to not only to the latest instrumentation, but also to experienced staff with expertise in designing and conducting experiments and analyzing data.”
Researchers at the University of Arizona recently received a $1.3 million new life science grant from the National Institutes of Health. The research funding was awarded in April of 2014 by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health. The project, entitled “The Cost-Effectiveness of School-Based Supervised Asthma Therapy” is being led by Dr. Lynn Gerald. Dr. Gerald is the Canyon Ranch Endowed Chair, Professor, and a Scientist in the Department of Health Promotion Sciences in the College of Public Health at the University of Arizona. In addition to this project receiving NIH research funding, her research interests include clinical, behavioral and epidemiological research in asthma, COPD, and tuberculosis.
Ovarian Cancer accounts for about 3% of cancers among women, but it causes more deaths than any other cancers of the female reproductive system. Recurrent Ovarian Cancer is almost always fatal, and new treatments are desperately needed.
University of Arizona researchers have identified genes within the human Cytomegalovirus, which could lead to targeted therapies that prevent disease caused by reactivation of the virus.
University of Arizona, Tucson doctoral student Sara Parker, alongside her adviser Sourav Ghosh (assistant professor of cellular and molecular medicine), have shed light on an unknown mechanism responsible for establishing polarity in developing nerve cells. This research, receiving life science funding from the National Institute of Health and Achievement Rewards for College Scientists Foundation, Inc. (awarded to Sara Parker), is allowing these scientists to understand how nerve cells make connections in the body.
Researchers at the University of Arizona recently received $1.2 million in NIH life science funding for a project titled “Selenium Colorectal Cancer Chemoprevention Agents.” The project start date is listed as August 1st, 2013. The NIH RePORTER goes into more detail about what the researchers are working to accomplish:
Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.
Tags: 2014, University of California Los Angeles, Harvard University, Rockefeller University, University of Arizona, University of Pittsburgh, Pennsylvania, Northeast, University of Pennsylvania, UPenn, New York, UPITT, Southwest, California, Los Angeles, Alabama, University of Alabama, Southern, Massachusetts, Life Science Company and Industry News Briefs, Arizona, Boston, LAVS, Philadelphia, UAZ, RockU, BioResearch Product Faire Event, UAlab, Harvard, Birmingham, Front Line, Tucson, Pittsburgh, Stony Brook, industry news, funding news, Science Market Update, Science Researcher Update, NIH grants, life science events, SunySB
A University of Arizona, Tucson researcher, Charles Raison, MD, recently received a 2013 IMHR Pilot Grant of $20,000 from the Institute for Mental Health Research to study the effects of whole body hyperthermia as an antidepressant. Dr. Raison is an associate professor of psychiatry in the College of Medicine and an associate professor in the College of Agriculture and Life Sciences, as well. His study is titled, “Antidepressant Effects of Whole Body Hyperthermia (WBH).”